|
[1] 陈功海,王广川,张春清. 特发性非肝硬化门静脉高压症诊治进展[J/CD]. 中华消化病与影像杂志(电子版),2021,11(3):132-138. DOI:10.3877/cma.j.issn.2095-2015.2021. 03.007.
[2] Sarin SK, Kumar A, Chawla YK, et al.
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL
recommendations for diagnosis and treatment[J]. Hepatol Int, 2007, 1(3):
398-413. DOI: 10.1007/s12072-007- 9010-9.
[3] 高帆,胡凤蓉,祁兴顺.«2015年欧洲肝病学会临床实践指南:肝脏血管病»摘译[J].临床肝胆病杂志,2016,32(1):40-43.
DOI: 10.3969/j.issn.1001-5256.2016.01.005.
[4] Saab S. Portal Hypertension[J]. Clin
Liver Dis, 2019, 23(4): xiii-xiv. DOI: 10.1016/j.cld.2019.08.001.
[5] Hernández-Gea V, Baiges A, Turon F, et
al. Idiopathic portal hypertension[J]. Hepatology, 2018, 68(6): 2413- 2423.
DOI: 10.1002/hep.30132.
[6] 赵连晖,贾继东. 特发性非肝硬化性门脉高压[J]. 肝脏,2019,24(3): 219-221. DOI:10.14000/j.cnki.issn.1008-
1704.2019.03.002.
[7] 黄海锋,舒建昌,陈健鑫,等.特发性门脉高压误诊为肝硬化1例报道[J]. 胃肠病学和肝病学杂志,2019,28(3):
356-357. DOI: 10.3969/j.issn.1006-5709.2019.03.025.
[8] Zhao ZL, Wei Y, Wang TL, et al. Author
correction:imaging and pathological features of idiopathic portal hypertension
and differential diagnosis from liver cirrhosis[J]. Sci Rep, 2020, 10(1): 7586.
DOI: 10.1038/s41598-020-63868-x.
[9] Sun Y, Lan X, Shao C, et al. Clinical
features of idiopathic portal hypertension in China: a retrospective study of
338 patients and literature review[J]. J Gastroenterol Hepatol, 2019, 34(8):
1417-1423. DOI: 10.1111/jgh.14552.
[10] Kmeid M, Liu X, Ballentine S, et al.
Idiopathic non-cirrhotic portal hypertension and porto-sinusoidal vascular
disease: review of current data[J]. Gastroenterology Res, 2021, 14(2): 49-65.
DOI: 10.14740/gr1376.
[11] Khanna R, Sarin SK. Noncirrhotic portal
hypertension: current and emerging perspectives[J]. Clin Liver Dis, 2019,
23(4): 781-807. DOI: 10.1016/j.cld.2019.07.006.
[12] 崔林阳,高璐璐,侯红军,等. 肝硬化伴脾功能亢进介入治疗临床应用及进展[J]. 国际医药卫生导报,2020,26(12): 1806-1810. DOI:
10.3760/cma.j.issn.1007-1245.2020. 12.050.
|
